Carlos Rosado

Title: Innovations of Carlos Rosado

Introduction

Carlos Rosado is an accomplished inventor based in Clayton, Australia. He has made significant contributions to the field of receptor biology, particularly in the modulation of the Receptor for Advanced Glycation End-products (RAGE). With a total of three patents to his name, Rosado's work has the potential to impact various therapeutic areas.

Latest Patents

Rosado's latest patents include innovative methods for screening candidate agents that can modulate RAGE activity. One of his notable patents describes a method of screening candidate agents for their ability to modulate RAGE activity induced by an active co-located GPCR. This method involves contacting a RAGE polypeptide with a GPCR polypeptide in the presence of a candidate agent, followed by detecting whether the candidate agent modulates RAGE activation. Another significant patent focuses on an isolated or purified AON for modifying pre-mRNA splicing in RAGE, which aims to modulate the splicing of the RAGE gene transcript.

Career Highlights

Throughout his career, Carlos Rosado has worked with prestigious institutions such as Beijing University of Technology and Murdoch University. His research has contributed to a deeper understanding of RAGE and its implications in various diseases. His innovative approaches have garnered attention in the scientific community.

Collaborations

Rosado has collaborated with notable colleagues, including Merlin Christopher Thomas and Raelene Jane Pickering. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Carlos Rosado's contributions to the field of receptor biology through his patents and collaborations highlight his role as a significant inventor. His work on RAGE modulation presents promising avenues for future research and therapeutic development.